HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide.

Abstract
The mechanism of action of pyrazinamide (PZA) is not known. One hypothesis is that PZA functions as a prodrug of pyrazinoic acid. Susceptibility to PZA correlates with amidase activity of the Mycobacterium tuberculosis isolate in question. PZA-resistant isolates retain susceptibility in vitro to pyrazinoic acid and n-propyl pyrazinoate. Esters of pyrazinoic acid appear to circumvent the requirement for activation by mycobacterial amidase. The MICs of n-propyl pyrazinoate for M. tuberculosis isolates are lower than those of pyrazinoic acid. Further studies to assess the effects of modifications of the alcohol and pyrazine moieties of pyrazinoate esters on in vitro and in vivo antituberculosis activity are under way. This may lead to a candidate compound with enhanced activity against both PZA-susceptible and PZA-resistant M. tuberculosis isolates suitable for clinical development.
AuthorsR J Speirs, J T Welch, M H Cynamon
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 39 Issue 6 Pg. 1269-71 (Jun 1995) ISSN: 0066-4804 [Print] United States
PMID7574514 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibiotics, Antitubercular
  • Niacin
  • Pyrazinamide
  • pyrazinoic acid
  • propyl pyrazinoate
  • Esterases
  • Amidohydrolases
  • pyrazinamide deamidase
Topics
  • Amidohydrolases (metabolism)
  • Antibiotics, Antitubercular (pharmacology)
  • Drug Resistance, Microbial
  • Esterases (metabolism)
  • Microbial Sensitivity Tests
  • Mycobacterium (drug effects, enzymology, metabolism)
  • Mycobacterium tuberculosis (drug effects, enzymology, metabolism)
  • Niacin (biosynthesis)
  • Pyrazinamide (analogs & derivatives, pharmacology)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: